Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_003690.5(PRKRA):c.861C>A(p.Ser287Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S287S) has been classified as Likely benign.
PRKRA (HGNC:9438): (protein activator of interferon induced protein kinase EIF2AK2) This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This sequence change affects codon 287 of the PRKRA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PRKRA protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PRKRA-related conditions. ClinVar contains an entry for this variant (Variation ID: 2124843). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -